Press release
Investigation announced for Investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
An investigation for investors in Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares over potential securities laws violations.
Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Regeneron Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Tarrytown, NY based Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
In 2020, The U.S. Attorney's office filed suit against Regeneron Pharmaceuticals, Inc.. The complaint alleged that Regeneron Pharmaceuticals, Inc. funneled tens of millions of dollars in kickbacks through a third-party foundation to ensure that few Medicare patients paid a co-pay on Eylea and that physicians who prescribed and purchased the drug did not have to collect Medicare co-pays from their patients. Regeneron Pharmaceuticals, Inc. allegedly paid these substantial sums only after confirming that the foundation needed the money to cover co-pays only for Eylea and not for competing drugs. The company's payments would generate a handsome return on investment, or 'ROI,' in the form of Medicare payments for Eylea. Furthermore, senior company executives allegedly took extensive measures to cover up the scheme.
Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) closed on March 25, 2022, at $680.03 per share.
Those who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) have certain options and should contact the Shareholders Foundation.
Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) here
News-ID: 2589232 • Views: …
More Releases from Shareholders Foundation
Investors in shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) should contact …
An investigation was announced for current long-term investors in shares of iRhythm Technologies, Inc. (NASDAQ: IRTC) concerning potential breaches of fiduciary duties by certain directors and officers of iRhythm Technologies, Inc..
Investors who are current long term investors in iRhythm Technologies, Inc. (NASDAQ: IRTC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long…
Investors in Thoughtworks Holding, Inc. (NASDAQ: TWKS) should contact the Shareh …
An investigation was announced concerning whether the takeover of Thoughtworks Holding, Inc. is unfair to NASDAQ: TWKS stockholders.
Investors who purchased shares of Thoughtworks Holding, Inc. (NASDAQ: TWKS) and currently hold any of those NASDAQ: TWKS shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors of Thoughtworks Holding, Inc. breached their…
Investigation announced for Investors who lost money with shares of Domino's Piz …
An investigation was announced for investors of Domino's Pizza, Inc. (NYSE: DPZ) shares over potential securities laws violations by Domino's Pizza, Inc.
Investors who purchased shares of Domino's Pizza, Inc. (NYSE: DPZ), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Domino's Pizza, Inc. (NYSE: DPZ)…
Investigation announced for Long-Term Investors in shares of Ocugen, Inc. (NASDA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Ocugen, Inc.
Investors who are current long term investors in Ocugen, Inc. (NASDAQ: OCGN) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: OCGN stocks follows a lawsuit filed against Ocugen, Inc. over alleged…
More Releases for Regeneron
Proliferative Diabetic Retinopathy Market Report- Growth Forecast Analysis by Ma …
The development variables of the Proliferative Diabetic Retinopathy Market are discussed in the research report. Furthermore, distinctive end clients of the market are clarified exhaustively. Information and data by the market player, by district, by type, by application. The Proliferative Diabetic Retinopathy Market report contains the SWOT examination of the worldwide Proliferative Diabetic Retinopathy Market.
Download FREE PDF of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5769912
By Company
- Intas Pharmaceuticals
- Santen Pharmaceutical
-…
Investigation announced for Investors in Regeneron Pharmaceuticals, Inc. (NASDAQ …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Regeneron Pharmaceuticals, Inc.
Investors who purchased shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and currently hold any of those NASDAQ: REGN shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Regeneron Pharmaceuticals directors breached their fiduciary duties and…
Antibody Cocktails Market to Witness Huge Growth by 2026 | Roche, Regeneron, Agi …
Global Antibody Cocktails Market Research Report 2016-2026 is latest research study released by HTF MI evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support. The report provides information on market trends and development, growth drivers, technologies, and the changing investment structure of the Global Antibody Cocktails Market. Some of the key players profiled in the study are Roche Holding AG, Regeneron Pharmaceuticals &…
Ophthalmology Drugs Market | Novartis, Regeneron, Roche, Bayer, Allergan, Shire, …
The Global Ophthalmology Drugs Market has witnessed continuous growth in the past few years and is projected to grow even further during the forecast period (2019-2025). The assessment provides a 360? view and insights, outlining the key outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions for improved profitability. In addition, the study helps venture or private players in understanding…
Retinal Drugs Market to see Huge Growth by 2025| Bayer, Novartis, Regeneron Merc …
The Exploration study offers deep assessment of the Global Retinal Drugs Market and helps market participants to gain a solid base in the industry. The Research report presents a complete assessment of the market and contains Future trend, Current Growth Factors, attentive opinions, historical data, facts and statistically supported and industry certified market data. It delivers regional exploration of the Global Retinal Drugs market to expose key prospects presented in…
Global Asthma Therapeutics Market 2018 - GSK, Merck, Regeneron, Sanofi, Novartis
Apex Market Research, recently published a detailed market research study focused on the "Asthma Therapeutics Market" across the global, regional and country level. The report provides 360° analysis of "Asthma Therapeutics Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Asthma Therapeutics industry, and estimates the future trend of Asthma Therapeutics market…
